Bellevue Asset Management’s GSK GSK Stock Holding History

Bellevue Asset Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$25.3K	Hold	482	–	–	0.01%	233
2026 Q1	$26.6K	Hold	482	–	–	0.01%	223
2025 Q4	$23.6K	Hold	482	–	–	0.01%	223
2025 Q3	$20.8K	Hold	482	–	–	0.01%	229
2025 Q2	$18.5K	Hold	482	–	–	0.01%	242
2025 Q1	$18.7K	Hold	482	–	–	0.01%	237
2024 Q4	$16.3K	Hold	482	–	–	0.01%	250
2024 Q3	$19.7K	Hold	482	–	–	0.01%	229
2024 Q2	$18.6K	Sell	482 -450	-48%	-$18.9K	0.01%	229
2024 Q1	$40K	Hold	932	–	–	0.02%	172
2023 Q4	$34.5K	Hold	932	–	–	0.03%	181
2023 Q3	$33.8K	Hold	932	–	–	0.02%	174
2023 Q2	$33.2K	Hold	932	–	–	0.02%	182
2023 Q1	$33.2K	Hold	932	–	–	0.02%	182
2022 Q4	$32.6K	Hold	932	–	–	0.03%	187
2022 Q3	$28K	Hold	932	–	–	0.02%	199
2022 Q2	$51K	Hold	932	–	–	0.04%	157
2022 Q1	$51K	Hold	932	–	–	0.03%	170
2021 Q4	$51K	Hold	932	–	–	0.03%	175
2021 Q3	$45K	Hold	932	–	–	0.03%	183
2021 Q2	$46K	Sell	932 -160	-15%	-$7.69K	0.03%	182
2021 Q1	$49K	Hold	1,092	–	–	0.03%	175
2020 Q4	$53K	Sell	1,092 -95	-8%	-$4.36K	0.03%	163
2020 Q3	$56K	Hold	1,187	–	–	0.04%	150
2020 Q2	$61K	Hold	1,187	–	–	0.06%	142
2020 Q1	$63K	Buy	1,187 +95	+9%	+$5.07K	0.07%	140
2019 Q4	$64K	Buy	+1,092	New	+$60.7K	0.05%	127

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Bellevue Asset Management's GSK Position: Q2 2026 in Review

Bellevue Asset Management held its GSK (GSK) position steady in Q2 2026 at 482 shares worth $25.3K. The position accounts for 0.01% of the portfolio, ranked #233.

Bellevue Asset Management first reported a position in GSK in Q4 2019 and has held it in 27 quarters since. The position peaked at $64K in Q4 2019. 1,045 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Bellevue Asset Management held 482 shares of GSK worth $25.3K as of Q2 2026.
Bellevue Asset Management left its GSK share count unchanged in Q2 2026.
GSK made up 0.01% of Bellevue Asset Management's portfolio in Q2 2026, its #233 holding.
Bellevue Asset Management first reported a position in GSK in Q4 2019 and has held it in 27 quarters since.
Bellevue Asset Management's GSK position peaked at $64K in Q4 2019.
1,045 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Bellevue Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.